Table 3.
MicroRNAs | Effects | Mechanisms | References |
---|---|---|---|
miR-204 | Prevented foam cell formation | Upregulated NFATc3 to reduce SR-A and CD36 levels | [46, 52] |
| |||
miR-181a-3p/5p | Delayed plaque formation | Reduced proinflammatory gene expression and macrophage infiltration | [24] |
| |||
miR-155 | Activated NLRP3 inflammasome | Blocking the ERK1/2 pathway | [51] |
| |||
miR-10a | Promoted mitochondrial oxidative metabolism in macrophages | Promoted Dicer/miR-10a-dependent metabolic reprograming | [48] |
| |||
miR-210 | Reduced ROS production and necroptosis | Upregulated the HIF-1α level | [49] |
| |||
miR-383 | Reduced energy consumption and increased cell survival | Blocked the targeting of Parg protein | [49] |
| |||
miR-155-5p | Mitigated vascular inflammation | Stimulated CTRP12 production | [47] |
| |||
miR-368a | Promoted reverse cholesterol transport | Reduced SIRPA expression | [50] |
| |||
miR-216a | Activated telomerase | Inhibited the Smad3/NF-κB signaling pathway | [53] |
NFATc3, nuclear factor of activated T cells 3; SR-A, the class A macrophage scavenger receptors; CD36, fatty acid translocase; NLRP3, NLR family pyrin domain containing 3; ERK1/2, extracellular signal-regulated protein kinase1/2; HIF-1α, hypoxia-inducible factor 1-α; CTRP12, C1q tumor necrosis factor-related protein 12; SIRPA, signal regulatory protein alpha; Smad3, suppressor of mothers against decapentaplegic 3; NF-κB, nuclear factor κB.